Veterinary Medicines Information website

Lactovac C

Not authorised
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
Download as PDF

Product identification

Medicine name:
Lactovac C
Active substance:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Bovine rotavirus A, strain 1005/78, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Bovine rotavirus A, strain Holland, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
  • Bovine coronavirus, strain 800, Inactivated
    1.00
    relative potency
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.00747.01.1
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/02/2022
Download